Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19.

Autor: Aguareles J; Internal Medicine Department. Hospital Universitario Quirónsalud Madrid, Madrid, Spain; Universidad Europea de Madrid, Madrid, Spain; Research and clinical trials unit, Hospital Universitario Quirónsalud Madrid, Madrid, Spain., Fernández PV; Internal Medicine Department. Hospital Universitario HM Sanchinarro, Madrid, Spain., Carralón-González MM; Internal Medicine Department. Hospital Universitario Quirónsalud Madrid, Madrid, Spain; Universidad Europea de Madrid, Madrid, Spain., Izquierdo CF; Heorfy Consulting, Lleida, Spain; Basic Medical Sciences Department, University of Lleida, Lleida, Spain., Martí-Ballesteros EM; Universidad Europea de Madrid, Madrid, Spain; Hematology Department, Hospital Universitario Quirónsalud Madrid, Madrid, Spain., Fernández VP; Universidad Europea de Madrid, Madrid, Spain; Hematology Department, Hospital Universitario Quirónsalud Madrid, Madrid, Spain., Sotres-Fernandez G; Internal Medicine Department. Hospital Universitario Quirónsalud Madrid, Madrid, Spain; Universidad Europea de Madrid, Madrid, Spain., García-Delangue T; Internal Medicine Department. Hospital HLA Universitario Moncloa, Madrid, Spain., LaPetra RGV; Internal Medicine Department. Hospital Universitario Quirónsalud Madrid, Madrid, Spain; Universidad Europea de Madrid, Madrid, Spain., Sánchez-Manzano MD; Internal Medicine Department. Hospital Universitario Quirónsalud Madrid, Madrid, Spain; Universidad Europea de Madrid, Madrid, Spain., Gutiérrez C; Universidad Europea de Madrid, Madrid, Spain; Research and clinical trials unit, Hospital Universitario Quirónsalud Madrid, Madrid, Spain., García-Coca M; Microbiology Department. Hospital Universitario Quirónsalud Madrid, Madrid, Spain., Carnevali-Ruiz D; Internal Medicine Department. Hospital Universitario Quirónsalud Madrid, Madrid, Spain; Universidad Europea de Madrid, Madrid, Spain., Barrena-Puertas R; Internal Medicine Department. Hospital Universitario Quirónsalud Madrid, Madrid, Spain; Universidad Europea de Madrid, Madrid, Spain., Luque-Pinilla JM; Internal Medicine Department. Hospital Universitario Quirónsalud Madrid, Madrid, Spain; Universidad Europea de Madrid, Madrid, Spain., Lloris R; Virology Unit, PharmaMar, S.A., Madrid, Spain., Luepke-Estefan XE; Coordinator of compassionate drug use, PharmaMar, S.A., Madrid, Spain., López-Martín JA; Virology Unit, PharmaMar, S.A., Madrid, Spain., Jimeno JM; Virology Unit, PharmaMar, S.A., Madrid, Spain., Guisado-Vasco P; Internal Medicine Department. Hospital Universitario Quirónsalud Madrid, Madrid, Spain; Universidad Europea de Madrid, Madrid, Spain. Electronic address: pablo.guisado@quironsalud.es.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2023 Oct; Vol. 135, pp. 12-17. Date of Electronic Publication: 2023 Jul 21.

Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort).

Autor: Guisado-Vasco P; Department of Internal Medicine. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Valderas-Ortega S; Nurse. Hospital Infectious Diseases Control Unit, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Carralón-González MM; Department of Internal Medicine. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Roda-Santacruz A; Research coordinator. Research and clinical trials unit, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., González-Cortijo L; Department of Oncology. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Sotres-Fernández G; Department of Internal Medicine. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Martí-Ballesteros EM; Department of Hematology, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Luque-Pinilla JM; Department of Internal Medicine. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Almagro-Casado E; Department of Oncology. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., La Coma-Lanuza FJ; Intensive Care Unit, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Barrena-Puertas R; Department of Internal Medicine. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Malo-Benages EJ; Department of Angiology and Vascular Surgery, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Monforte-Gómez MJ; Department of Internal Medicine, Hospital quironsalud San Jose, Madrid, Spain., Diez-Munar R; Department of Anesthesiology, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Merino-Lanza E; Department of Cardiology, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Comeche-Casanova L; Department of Pneumology, Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Remirez-de-Esparza-Otero M; Pharmacy Unit, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Correyero-Plaza M; Department of Rheumatology, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Recio-Rodríguez M; Department of Radiology department, Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Rodríguez-López M; Department of Endocrinology, Hospital universitario quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain., Sánchez-Manzano MD; Department of Internal Medicine. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Andreu-Vázquez C; Statistical section, Faculty of Biomedical Science and Health, Universidad Europea (Madrid), Villaciosa de Odón, Madrid, Spain., Thuissard-Vasallo IJ; Statistical section, Faculty of Biomedical Science and Health, Universidad Europea (Madrid), Villaciosa de Odón, Madrid, Spain., María-Tomé JME; Department of Pneumology, Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain., Carnevali-Ruiz D; Department of Internal Medicine. Hospital universitario quironsalud Madrid, Universidad Europea (Madrid), Pozuelo de Alarcon, Madrid, Spain.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2020 Nov; Vol. 28, pp. 100591. Date of Electronic Publication: 2020 Oct 15.

Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR).

Autor: Olivares JM; Department of Psychiatry, Hospital Meixoeiro, Complejo Hospitalario Universitario de Vigo, Vigo Spain. jose.manuel.olivares@gmail.com, Rodriguez-Morales A, Diels J, Povey M, Jacobs A, Zhao Z, Lam A, Villalobos Vega JC, Cuéllar JA, de Castro FJ, Quintero CM, Martíin JF, Domínguez P, Ojeda JL, Cortés SS, Cala FI, Marín CG, Castro LM, Duaso MA, Albarracín JR, Vergara GN, Benítez AF, Cleries FM, Pérez-Brian JM, Aragón AB, Navarro JC, Biedma JA, de Pedro RB, González JF, López ME, Moreno HD, López JA, Rodríguez EO, de Hoyos CM, Sacristán MP, Martín MD, Ballesteros EM, Rodríguez PA, Menéndez LF, Rivas RS, del Pino Cuadrado P, Lauffer JC, Solano JJ, Martínez JM, Solano FG, Rodríguez PG, Rodríguez JA, Cano TR, Fortacin MD, Lobeiras JM, Sampedro JM, Bravo AP, Pellicer AF, López MD, Liste JF, Fernández MR, Losada AC, Mendez RV, Romero SA, Blanco JJ, Bonaselt IT, Mahia MC, del Valle EF, Yañez PQ, Camarasa MG, Alonso JA, Mendez GF, Feliz FD, Lamela MA, Piñero MV, Alvarado PF, Gómez IL, Martín PF, Gómez JL, López AG, Jiménez AR, Nafs AE, Barquero NC, Ortiz RF, Noguera JL, Carrasco PR, Muñoz JM, Palma MM, Hortelano CM, Bonome LS, Sevilla JS, Juan JM, Ramos JM, Muñoz JL, Guisasola JE, Vazquez LS, Guerras FC, Nebot FJ, Fernández FJ, Nicolau AL, Subirats RC, Kidias MM, Navarro VF, García BF, del Rosal FM, de Vicente Muñoz T, Ballester JA, Lieb PM, Martel AD, Bea ER, Joaquim IG, Enjuanes FB, Piñol MB, Carbonell EF, Muñoz RM, Giribets CA, Sans LA, Blanco AS, Felipe MA, Muñoz PG, Villanueva AP, Arroyo MB, Borri RC, Fallada SM, Merola MC, Rodon EP, Palmes JR, Martínez EP, Catala JM, Coca AS, Ferrandiz FP, Paya EF, Caballero GI, Bonet AF, Figueras JF, Pagador PM, Garibo MM, Camo VP, Carrillo CS, Valero CP, Rebollo FJ, García Campayo J, Sala Ayma JM, Roig MM, de Uña Mateos MA, Bertolin RG, García AM, Mazo FJ, Velasco JL, Pérez LS, Casado CJ, Barba JJ, Diaz MC, Rubio JP, Mandoli AS, Herrero AU, Martínez AR, Serrano PS, Rodríguez EN, Montesinos JS, Macia JF, Mateos Marcos AM, Soto JV, Dumont MV, Pagan JP, Martínez VB, Santiuste de Pablos M, Delgado CE, Quiles MD, López FJ, Navarro PP, Torres AM, Ingles FJ, Arias-Camison JM, Manzano JC, Peña RV, Guitarte GP, Fontecilla HB, Romero JB, Gil RS, Lozano JM, Adanez LD, Zarranz Herrera-Oria I, Jiménez JP, Vaz FC, García OS, Anton CC, Casula RR, Hernandez MC, Escabias FT, Torresano JR, Pérez-Villamil AH, Estevez L, Figuero MA, Muñoz de Morales A, Calvin JL, Criado MD, Rodríguez VM, Ambrosolio EB, Madera PM, Alfaro GP, Vidal MM, Valtuille AG, Ruiz O, Cabornero GL, Echevarria Martínez de Bujo M, Mallen MJ, Puigros JS, Martorell AL, Forteza AC, Arrebola ER, Rodríguez de la Torre M, Saiz CG, Bardolet I Casas C, Linde ER, De Arce Cordon R, Molina EM, Carazo FJ, Romero JJ, Cano DV, Dorado MS, Velazquez SC, Sánchez AJ, Leon SO, Sánchez KP, Benitez MH, Zugarramurai AI, Contreras MA, De la Varga González M, Marín PB, Robina FG, García MS, Pérez FJ, Bros PC, Gómez AC, de Dios Molina Martín J, Perera JL, Averbach MC, Perera JL, Palancares EG, Gallego de Dios MT, Rojo CF, Iglesias SS, Merino MI, Mestre NP, Urdaniz AP, Sánchez JM, Seco RG, Muñoz JF, Agut MM, Lozano ML, Herguedas FM, Pena AT, García JV, Martínez AV, Sanz Granado OS, Fernández MA, Canseco JM, López PA, Martín MA, Barrio JA, Ubago JG, Bennassar MR, Díez JM, Fleta JL, Fortes FP, López CA, Medina O, Alvarez DF, Roca JM, Valladolid GR, Tavera JA, García-Castrillon Sales JA, Llordes IB, Melgarejo CA, Cañas de la Paz F, Callol VV, García MB, García JB, Leal FJ, Corrales EC, Iglesias ES, Gómez MA, Serrano GG, Chillarón EG, Aguado FJ, Castillo JJ, González AG, Vázquez JG, Peralvarez MB, Diaz MR, Mesa MY, Artiles FJ, Chao MA, Mesa MY, del Rosario Santana P, Escudero MA, Berenguer MM, Llacer JM, Berna JA, Ortiz JB, Pardell LT, Hernández-Alvarez de Sotomayor C, Méndez MR, Garate RC, Múgica BD, González MC, Domingo JP, Navarro CS, Vera GS, Cuquerella MA, Monzo JL, Boada PC, Pérez MF, Parrado EC, Sánchez JJ, Fernández JC

Publikováno v: European psychiatry : the journal of the Association of European Psychiatrists [Eur Psychiatry] 2009 Jun; Vol. 24 (5), pp. 287-96. Date of Electronic Publication: 2009 Feb 04.

EEF1A2 identified as a hub gene associated with the severity of metabolic dysfunction-associated steatotic liver disease.

Autor: Zhang J; Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, China., Wang H; Department of Infection Control Center of Xiangya Hospital, Central South University, Changsha, Hunan, China., Wang Q; Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, China., Mo J; Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, China., Fu L; Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, China. fulei92@126.com., Peng S; Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, China. sfp1988@csu.edu.cn.

Publikováno v: Mammalian genome : official journal of the International Mammalian Genome Society [Mamm Genome] 2024 Oct 16. Date of Electronic Publication: 2024 Oct 16.

A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity.

Autor: Xu, Jie¹, Xiao, Wenwei¹, Liang, Xuan¹, Shi, Li¹, Zhang, Peihua¹, Wang, Ying¹, Wang, Yadong², Yang, Haiyan¹ yhy@zzu.edu.cn

Publikováno v: BMC Public Health. 8/11/2021, Vol. 21 Issue 1, p1-49. 49p. 1 Diagram, 3 Charts, 3 Graphs.